Tau truncation in Alzheimer's disease: expression of a fragment encompassing PHF core

Alzheimer's Reports

Volumn 1, Issue 1, 1998, Pages 25-32

  Fasulo, Luisa ^a   Visintin, Michela ^a   Novak, Michela ^a,b   Cattaneo, Antonio ^a  

^a SISSA   (Italy)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22044447582     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alzheimer A (1907). Uber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat 64, 146-148.
2. Anderson AJ, Su JH and Cotman CW (1996). DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16, 1710-1719.
3. Bednarski E and Lynch G (1996). Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J Neurochem 67, 1846-1855.
4. Blessed G, Tomlinson BE and Roth M (1968). The association between qualitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114, 797-811.
5. Bondareff W, Wischik CM, Novak M and Roth M (1991). Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. Am J Pathol 139, 641-647.
6. Braak H and Braak E (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
7. Cataldo AM, Bamett JL, Berman SA et al., (1995). Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14, 671-680.
8. Dickson DW, Ksiezak-Reding H, Liu W-K et al., (1992). Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: Identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathologica. 84, 596-605.
9. Fasulo L, Ovecka M, Kabat J et al., (1996). Overexpression of Alzheimer's PHF core tau fragments: Implications for the tau truncation hypothesis. Alzheimer's Res 2, 195-200.
10. Goedert M, Spillantini MG, Cairns NJ and Crowther RA (1992). Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
11. Goedert M, Jakes R, Spillantini MG et al., (1996). Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553.
12. Greenberg SG and Davies P (1990). A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87, 5827-5831.
13. Grundke-Iqbal I, Iqbal K, Tung Y-C et al., (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
14. Gustke N, Trinczek B, Biemat J et al., (1994). Domains of tau protein and interactions with microtubules. Biochemistry 33, 9511-9522.
15. Jakes R, Novak M, Davison M and Wischik CM. (1991). Identification of 3-and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J 10, 2725-2729.
16. Johnson GVW, Seubert P, Cox TM et al., (1997). The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem 68, 430-433.
17. Kanai Y, Chen J and Hirokawa N (1992). Microtubule bundling by tau proteins in vivo: Analysis of functionaldomains. EMBO J 11, 3953-3961.
18. Kidd M (1963). Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197, 192-193.
19. Lassmann H, Bancher C, Breitschopf H et al., (1995). Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89, 35-41.
20. Lee G and Rook SL (1992). Expression of tau protein in non-neuronal cells: Microtubule binding and stabilization. J Cell Sci 102, 227-237.
21. Lee VM-Y, Balin BJ, Otvos L Jr and Trojanowski JQ (1991). A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675-678.
22. Morishima-Kawashima M, Hasegawa M, Takio K et al., (1995). Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 270, 823-829.
23. Novak M (1994). Truncated tau protein as a new marker for Alzheimer's disease. Acta Virologica 38, 173-189.
24. Novak M, Kabat J and Wischik CM (1993). Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12, 365-370.
25. Novak M, Wischik CM, Edwards PC et al., (1989). Characterization of the first monoclonal antibody against the pronase resistant core of the paired helical filament. Progr Clin Biol Res 317, 755-761.
26. Saito KI, Elce JS, Hamos JE et al., (1993). Widespread activation of calpain in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90, 2628-2632.
27. Su JH, Anderson AJ, Cummings BJ and Cotman CW (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5, 2529-2533.
28. Tewari M, Quan LT, O'Rourke K et al., (1995). Yama/CPP32beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809.
29. Ugolini G, Cattaneo A and Novak M (1997). Co-localisation of truncated tau and DNA fragmentation in Alzheimer disease neurons. NeuroReport 8, 3709-3712.
30. Wang J-Z, Grundke-Iqbal I and Iqbal K (1996). Glycosylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer's disease. Nature Med 2, 871-875.
31. Wischik CM, Novak M, Thøgersen HC et al., (1988a). Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 85, 4506-4510.
32. Wischik CM, Novak M, Edwards PC et al., (1988b). Structural characterisation of the core of the paired helical filament of Alzheimer's disease. Proc Natl Acad Sci USA 85, 4884-4888.
33. Yamatsuji T, Okamoto T, Takeda S et al., (1996a). Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J 15, 498-509.
34. Yamatsuji T, Matsui T, Okamoto T et al., (1996b). G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272, 1349-1352.
35. Yankner BA (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.